The Government Accountability Office (GAO) today released the following testimony:
Testimony 1. Drug Safety: Preliminary Findings Suggest Recent FDA Initiatives Have Potential, but Do Not Fully Address Weaknesses in Its Foreign Drug Inspection Program, by Marcia G. Crosse, director, health care, before the Subcommittee on Oversight and Investigations, House Committee on Energy and Commerce. GAO-08-701T, April 22. http://www.gao.gov/cgi-bin/getrpt?GAO-08-701T Highlights - http://www.gao.gov/highlights/d08701thigh.pdf Help with viewing PDF files is available from the "Help" section of http://www.gao.gov. Check the information in the section titled, "Help with Reading Portable Document Format Files" if you have difficulty. Subscribe to this or other E-mail updates about GAO products at the "E-mail Updates" section of http://www.gao.gov. Remove yourself from this mailing list by sending an E-mail message to: [EMAIL PROTECTED] with the message: unsubscribe daybook in the message body. Order printed copies of any of these items from GAO: 202-512-6000 (voice) 202-512-2537 (TDD) 202-512-6061 (fax). Members of the press may request copies from the Office of Public Affairs, 202-512-4800. =========================================================== This list is produced by the Government Accountability Office to provide daily information about GAO Reports and Testimonies. Visit GAO on the web at http://www.gao.gov
